Description: An analysis of US population mortality trends and the impact of COVID.

Description: This is an article about The SOA’s Committee on Life Insurance Company Expenses CLICE and its completion of its fourth inter-company study of expenses for individual life and annuity business issued in the United States.

Description: Highlights from the 2002 Inter-Company Expense Study of U.S. Individual Life Insurance and Annuities.

Description: This article details different methods for calculating mortality impact associated with new underwriting programs. A common simplified calculation is compared and contrasted with two first principles approaches. The strengths and weaknesses of both approaches are discussed.

Description: This article provides a description of the development process for the 2003 GRET factors. The results were also presented and discussed.

Description: After years of discussion and debate, PrinciplesBased Reserving (PBR) is finally a reality. Small insurance companies have a unique opportunity to decide between electing for the company-wide exemption or adopting the PBR methods. This article discusses the benefits and challenges of the options available to small insurers under VM-20 as well as best practices that have been found along the way.

Description: The South African life insurance industry contains the largest life insurance market in Africa, it is highly sophisticated and highly regulated. In the years 2020 and2021, the industry suffered significant mortality losses due toCovid-19. What can we learn from this experience in South Africa?

Description: Provides a review of the available lapse experience for lapse-supported Life and Long-Term Care products.

Description: Future mortality improvement has been a common assumption in life insurance and annuity pricing and forecasting for many years. However, experience over the last decade suggests this might be an assumption that merits reconsideration in the United States. This article will take a closer look at factors that impact mortality improvement trends and discuss why insurers may want to reevaluate product designs to better manage the associated mortality risk. We then introduce a product idea with this in mind, where premiums are based on a life expectancy index and insurers share the risk (and opportunity) or mortality improvement with policyholders.